https://orcid.org/0000-0003-4868-7158
References
- Borne RT, O'Donnell C, Turakhia MP, et al. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration. BMC Cardiovasc Disord. 2017;17:236.
- Alberts MJ, Peacock WF, Fields LE, et al. Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke. Int J Cardiol. 2016;215:11–13.[
- Taitel M, Fensterheim L, Kirkham H, et al. Medication days' supply, adherence, wastage, and cost among chronic patients in medicaid. Medicare Medicaid Res Rev. 2012;2(3):mmrr.002.03.a04.
- Watson Health. IBM MarketScan Research Databases for life sciences researchers.© IBM Corporation; 2020. [cited April 6, 2021]. Available from: https://www.ibm.com/downloads/cas/OWZWJ0QO.
- McHorney CA, Peterson ED, Ashton V, et al. Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients. Curr Med Res Opin. 2019;35:653–660.
- Nelson WW, Song X, Coleman CI, et al. Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation. Curr Med Res Opin. 2014;30:2461–2469.
- Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399–424.
- Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
- Centers for Medicare and Medicaid Services. CMS Chronic Conditions Data Warehouse Condition Categories. [cited 2021 Aug 7]. Available from: https://www2.ccwdata.org/web/guest/condition-categories
- Canfield SL, Zuckerman A, Anguiano RH, et al. Navigating the wild west of medication adherence reporting in specialty pharmacy. J Manag Care Spec Pharm. 2019;25:1073–1077.
- Pharmacy Quality Alliance. Adherence to Direct-Acting Oral Anticoagulants (PDC-DOAC). [cited 2021 Jan 31]. Available from: www.pqaalliance.org/measures-overview#pdc-doac
- Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323(23):2417–2418.
- Langan SM, Schmidt SA, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532.
- Ozaki AF, Choi AS, Le QT, et al. Real-World adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2020;13:e005969.
- Deshpande CG, Kogut S, Willey C. Real-World health care costs based on medication adherence and risk of stroke and bleeding in patients treated with novel anticoagulant therapy. J Manag Care Spec Pharm. 2018;24:430–439.
- Gandhi SK, Salmon W, Kong SX, et al. Administrative databases and outcomes assessment: an overview of issues and potential utility. J Manag Care Spec Pharm. 1999;5(3):215–222.
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
- Weeda ER, Coleman CI, McHorney CA, et al. Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: a meta-regression analysis. Int J Cardiol. 2016;216:104–109.